Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions

Yanping GUO, Qing YANG, Shirui WANG, Simin LI, Boyang YU, Xiaofeng YANG

Acta Academiae Medicinae Sinicae ›› 2024, Vol. 46 ›› Issue (3) : 329-333.

PDF(1386 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(1386 KB)
Acta Academiae Medicinae Sinicae ›› 2024, Vol. 46 ›› Issue (3) : 329-333. DOI: 10.3881/j.issn.1000-503X.15734
Original Articles

Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions

Author information +
History +

Abstract

Objective to evaluate the value of SOX1 and PAX1 gene methylation detection in the secondary triage of high-grade cervical lesions.Methods Exfoliated cervical cells were collected from 122 patients tested positive for human papilloma virus(HPV)and subjected To thin-prep cytologic test(TCT)and SOX1/PAX1 gene methylation tests.Results the HPV test combined with TCT showed the sensitivity of 95.24%and the specificity of 23.75%for detecting cervical intraepithelial neoplasia(CIN)grade 2 and above(CIN2+).After the addition of the SOX1/PAX1 gene methylation detection in secondary triage,the sensitivity for detecting CIN2+was 83.33%,which had no statistically significant difference from the sensitivity of TCT combined with HPV test(P=0.078).However,the specificity reached 77.50%,which was significantly higher than that of HPV test combined with TCT(P<0.001).the SOX1/PAX1 gene methylation level in the CIN2+group was higher than those in the normal cervical tissue and the CIN1 group(P<0.001).the cut-off values of SOX1 and PAX1 gene methylation for CIN2+detection were-11.81 and-11.98,respectively.Conclusion Adding the detection of SOX1/PAX1 gene methylation in secondary triage significantly improves the efficiency and accuracy of CIN2+detection。

Key words

SOX1 / PAX1 / methylation / cervical lesion

Cite this article

Download Citations
Yanping GUO , Qing YANG , Shirui WANG , et al . Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions[J]. Acta Academiae Medicinae Sinicae. 2024, 46(3): 329-333 https://doi.org/10.3881/j.issn.1000-503X.15734

References

[1]
郑荣寿, 张思维, 孙可欣, 等. 2016年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2023, 45(3):212-220.DOI:10.3760/cma.j.cn112152-20220922-00647.
[2]
Gao G, Smith DI. Human papillomavirus and the development of different cancers[J]. Cytogenet Genome Res, 2016, 150(3-4):185-193.DOI:10.1159/000458166.
[3]
Koliopoulos G, Nyaga VN, Santesso N, et al. Cytology versus HPV testing for cervical cancer screening in the general population[J]. Cochrane Database Syst Rev, 2017, 8(8):CD008587.DOI:10.1002/14651858.CD008587.pub2.
[4]
王攀, 赵洪林, 任凡, 等. 表观遗传学在恶性肿瘤发生发展和治疗中的新进展[J]. 中国肺癌杂志, 2020, 23(2):91-100.DOI:10.3779/j.issn.1009-3419.2020.02.04.
[5]
刘贽, 席金瓯, 夏剑波. 抑癌基因DNA异常甲基化与宫颈癌研究进展[J]. 微循环学杂志, 2019, 29(3):75-78.DOI:10.3969/j.issn.1005-1740.2019.03.017.
[6]
Chen Y, Cui Z, Xiao Z, et al. PAX1 and SOX1 methylation as an initial screening method for cervical cancer:a meta-analysis of individual studies in Asians[J]. Ann Transl Med, 2016, 4(19):365.DOI:10.21037/atm.2016.09.30.
[7]
Lai HC, Lin YW, Huang TH, et al. Identification of novel DNA methylation markers in cervical cancer[J]. Int J Cancer, 2008, 123(1):161-167.DOI:10.1002/ijc.23519.
[8]
Nayar R, Wilbur DC. The Pap test and Bethesda 2014[J]. Cancer Cytopathol, 2015, 123 (5):121-132.DOI:10.1002/cncy.21521.
[9]
余艳琴, 郝金奇, 徐慧芳, 等. 宫颈癌综合预防和控制的应用和前景[J]. 中国医学科学院学报, 2020, 42(4):535-539.DOI:10.3881/j.issn.1000-503X.11370.
[10]
Bruhn LV, Andersen SJ, Hariri J. HPV-testing versus HPV-cytology co-testing to predict the outcome after conization[J]. Acta Obstet Gynecol Scand, 2018, 97(6):758-765.DOI:10.1111/aogs.13325.
[11]
陈丛, 赵敏. DNA甲基化预测宫颈病变研究进展[J]. 国际妇产科学杂志, 2021, 48(5):535-538.DOI:10.12280/gjfckx.20201124.
[12]
Lorincz AT. Virtues and weaknesses of DNA methylation as a test for cervical cancer prevention[J]. Acta Cytol, 2016, 60(6):501-512.DOI:10.1159/000450595.
[13]
程媛, 魏丽惠, 王建六. PAX1基因及其甲基化在宫颈癌作用的分子机制研究进展[J]. 实用妇产科杂志, 2016, 32(11):823-825.
[14]
Lai HC, Ou YC, Chen TC, et al. PAX1/SOX1 DNA methylation and cervical neoplasia detection:a Taiwanese Gynecologic Oncology Group (TGOG) study[J]. Cancer Med, 2014, 3(4):1062-1074.DOI:10.1002/cam4.253.
[15]
Huang J, Tan ZR, Yu J, et al. DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma[J]. Onco Targets Ther, 2017, 10:4739-4751.DOI:10.2147/OTT.S143389.
[16]
Wei Y, Wang W, Cheng M, et al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 266:182-186.DOI:10.1016/j.ejogrb.2021.09.027.
[17]
谌媛媛, 李静. 宫颈脱落细胞中PAX1和SOX1基因甲基化对宫颈癌实验诊断的临床研究[J]. 现代检验医学杂志, 2022, 37(6):46-51.DOI:10.3969/j.issn.1671-7414.2022.06.009.
[18]
Li M, Zhao C, Zhao Y, et al. Association and effectiveness of PAX1 methylation and HPV viral load for the detection of cervical high-grade squamous intraepithelial lesion[J]. Pathogens, 2023, 12(1):63.DOI:10.3390/pathogens12010063.
[19]
Li M, Zhao C, Zhao Y, et al. The role of PAX1 methylation in predicting the pathological upgrade of cervical intraepithelial neoplasia before cold knife conization[J]. Front Oncol, 2023, 12:1064722.DOI:10.3389/fonc.2022.1064722.
PDF(1386 KB)

Accesses

Citation

Detail

Sections
Recommended

/